THE EFFECT OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS ON RENAL OUTCOMES IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION.

被引：0
|
作者：
Deeprom, Siwaporn [1 ,2 ]
Chirananthavat, Thanit [2 ]
机构：
[1] San Pa Tong Hosp, Med, Chiangmai, Thailand
[2] Police Gen Hosp, Nephrol, Bangkok, Thailand
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P0706
引用
收藏
页码：1028 / 1028
页数：1
相关论文
共 50 条
  • [41] Use of non-vitamin K antagonist oral anticoagulants in frail patients with atrial fibrillation
    Ortigoza, Daniel, V
    Valentino, Mariana
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2021, 50 (02): : 43 - 48
  • [42] Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with bioprosthetic valves
    Andrade, Jason G.
    Meseguer, Elena
    Didier, Romain
    Dussault, Charles
    Weitz, Jeffrey I.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2018, 16 (06) : 413 - 418
  • [43] Renal outcomes in Asian patients receiving oral anticoagulants for non-valvular atrial fibrillation
    Shahzada, Tayyab Salim
    Guo, Cosmos L.
    Lee, Alex P. W.
    HONG KONG MEDICAL JOURNAL, 2022, 28 (01) : 24 - 32
  • [44] Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants?
    Mlodawska, Elzbieta
    Lopatowska, Paulina
    Malyszko, Jolanta
    Banach, Maciej
    Sobkowicz, Bozena
    Covic, Adrian
    Tomaszuk-Kazberuk, Anna
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (09) : 1633 - 1642
  • [45] Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants?
    Elzbieta Mlodawska
    Paulina Lopatowska
    Jolanta Malyszko
    Maciej Banach
    Bożena Sobkowicz
    Adrian Covic
    Anna Tomaszuk-Kazberuk
    International Urology and Nephrology, 2018, 50 : 1633 - 1642
  • [46] Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a systematic and qualitative review
    Liberato, Nicola Lucio
    Marchetti, Monia
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (02) : 221 - 235
  • [47] Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study
    Douros, Antonios
    Renoux, Christel
    Coulombe, Janie
    Suissa, Samy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (12) : 1546 - 1554
  • [48] Renal function outcomes among non-valvular atrial fibrillation patients on Warfarin and non-vitamin K oral anticoagulants: A multicenter, propensity-matched retrospective analysis
    Koh, H. P.
    Nagarajah, J. R.
    Tay, S. L.
    Tang, J. Y.
    Hoo, Y. Y.
    Mohamed, S.
    Chua, C. Z. F.
    Tan, S. L.
    Ong, S. J.
    Radhakrishnan, S.
    Zamani, N.
    Arumugam, P. K. N.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 393
  • [49] Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials
    Vedovati, M. C.
    Giustozzi, M.
    Becattini, C.
    Conti, S.
    Verdecchia, P.
    Cianella, F.
    Marchesini, E.
    Verso, M.
    Filippucci, E.
    Agnelli, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 905 - 905
  • [50] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation and valvular heart disease
    Li, Hsing-Jung
    Lin, Shin-Yi
    Lin, Fang-Ju
    Hung, Chi-Sheng
    Wang, Chi-Chuan
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (04) : 535 - 542
12345